Details for New Drug Application (NDA): 006823
✉ Email this page to a colleague
NDA 006823 describes AQUASOL A, which is a drug marketed by Astrazeneca and Casper Pharma Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the AQUASOL A profile page.
The generic ingredient in AQUASOL A is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
The generic ingredient in AQUASOL A is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
Summary for 006823
| Tradename: | AQUASOL A |
| Applicant: | Casper Pharma Llc |
| Ingredient: | vitamin a palmitate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 006823
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AQUASOL A | vitamin a palmitate | INJECTABLE;INJECTION | 006823 | NDA | Casper Pharma LLC | 70199-026 | 70199-026-11 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70199-026-11) / 2 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50,000 UNITS BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
